Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- Chuikyo Payer Rep Touts Necessity of FY2025 Off-Year Price Revision
November 19, 2024
- Japan, US, Europe Trade Groups Urge Ishiba Govt to Scrap Off-Year Revisions
November 18, 2024
- JPMA Appreciates Growing Calls for Abolition of Off-Year Revisions: Exec
November 15, 2024
- Osaka’s New Life Science Hub to Grow into Full Ecosystem in 5 Years: Operator
November 12, 2024
- Self-Medication and Proper Drug Pricing 2 Sides of the Same Coin: Professor
November 8, 2024
- Japan Wholesaler Group to Continue Stressing Plight of Supply Disruption
October 25, 2024
- Drug Therapy for Fetal Tachyarrhythmia Gets 1st Health Coverage in Japan
October 21, 2024
- Off-Year Price Revision Has Accomplished Mission: JPMA Exec
October 18, 2024
- JaDHA Inks MOU with DTA to Collaborate in DTx Push
October 16, 2024
- JaDHA Creates Hypothetical Case Collection to Push Two-Stage Approval of SaMD
October 11, 2024
- EFPIA Chief Sees Positive Signal from Japan Policymakers, Calls for Consistency
October 11, 2024
- EFPIA Japan Chair Urges All Players to Join Forces in Drug Loss Fight
October 10, 2024
- New Administration Must Not Stop Efforts toward Bolstering Pharma Industry: JPMA Chief
October 9, 2024
- Pharma Labor Group Renews Call for Abolition of Off-year Revisions
October 9, 2024
- Policy Veterans’ Group Proposes Special Drug Price Rule for Antibiotics
October 3, 2024
- Japan Generic Use Rate Reaches 83.5% in April-June: JGA
September 30, 2024
- Japan Wholesalers Enjoy Growth as COVID Meds Enter Commercial Route
September 27, 2024
- Keidanren Calls for Review of Japan's Unique Pharmaceutical Regulations
September 19, 2024
- Pharma Industry Prepares List of 68 Lawmakers to Support in Likely Snap Poll
September 12, 2024
- Japan’s Generic Use Rate at 82.7% in FY2023: JGA
August 1, 2024
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…